smallpox vaccine cj-50300
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
3
Phase 4
0
Earliest trial started Jan 1, 2008 (NCT00607243)
Timeline
Indications
Studied for
Mechanism of action
- Variola virusImmunity, active
Variola virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- smallpox vaccine cj-50300
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01317238 | Phase 3 | Oct 1, 2010 | CJ HealthCare Corp., Seoul National University |
| NCT01056770 | Phase 3 | Oct 1, 2009 | CJ HealthCare Corp., Seoul National University |
| NCT00607243 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2008 | CJ HealthCare Corp., Seoul National University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CJ HealthCare Corp. | For profit | 3 | 0 | 1 | 2008 |
| Seoul National University | Academic/Hospital | 3 | 3 | 1 | 2008 |
2 organizations
Page 1 / 1